Home/Filings/4/0001093557-21-000286
4//SEC Filing

Regan Barry J. 4

Accession 0001093557-21-000286

CIK 0001093557other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:39 PM ET

Size

5.2 KB

Accession

0001093557-21-000286

Insider Transaction Report

Form 4
Period: 2021-12-15
Regan Barry J.
EVP Operations
Transactions
  • Award

    Common Stock

    2021-12-15$0.00/sh+1,671$213,128 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/2 shall vest 24 months from the Grant Date, 1/8 shall vest 27 months from the Grant Date, 1/8 shall vest 30 months from the grant date, 1/8 shall vest 33 months from the Grant Date, and the remaining balance shall vest 36 months from the Grant Date. Share units represent a contingent right to receive one share of DexCom Inc. Common Stock.
  • [F2]Included in this number are 13,128 unvested restricted stock units, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001746313

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:39 PM ET
Size
5.2 KB